Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.310 | ||||||
REV | 314.767K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
PRQR | ProQR Therapeutics | 4.52 | -0.11 | -2.38% | 226.9M |
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Other companies in ProQR Therapeutics’s space includes: AVEO Pharmaceuticals (NASDAQ:AVEO), Galecto (NASDAQ:GLTO) and Cabaletta Bio (NASDAQ:CABA).
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Chardan Capital on 2020-08-11. The analyst firm set a price target for 20.00 expecting PRQR to rise to within 12 months (a possible 342.48% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $4.52 last updated Today at 6:41:29 PM.
There are no upcoming dividends for ProQR Therapeutics.
There is no upcoming split for ProQR Therapeutics.